Kim NH - Search Results

1

Pharmacogenetic study of deferasirox, an iron chelating agent.

Lee JW, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS. Lee JW, et al. Among authors: kim h, kim nh. PLoS One. 2013 May 30;8(5):e64114. doi: 10.1371/journal.pone.0064114. Print 2013. PLoS One. 2013. PMID: 23737969 Free PMC article.

2

Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.

Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS. Lee J, et al. Among authors: kim yk, kim nh, kim ec. J Antimicrob Chemother. 2007 Sep;60(3):629-37. doi: 10.1093/jac/dkm225. Epub 2007 Jun 27. J Antimicrob Chemother. 2007. PMID: 17599919

3

Development of multiplex PCR method for the analysis of glutathione s-transferase polymorphism.

Kim MS, Kang HJ, Park HJ, Yook YJ, Han BD, Kim CW, Kim NH, Lee JW, Kim H, Park KD, Shin HY, Ahn HS. Kim MS, et al. Among authors: kim h, kim cw, kim nh. Mol Diagn Ther. 2011 Oct 1;15(5):285-92. doi: 10.1007/BF03256420. Mol Diagn Ther. 2011. PMID: 22047155

4

Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.

Lee JW, Kang HJ, Lee SH, Yu KS, Kim NH, Yuk YJ, Jang MK, Han EJ, Kim H, Song SH, Park KD, Shin HY, Jang IJ, Ahn HS. Lee JW, et al. Among authors: kim h, kim nh. Biol Blood Marrow Transplant. 2012 Jun;18(6):944-50. doi: 10.1016/j.bbmt.2011.11.025. Epub 2011 Dec 7. Biol Blood Marrow Transplant. 2012. PMID: 22155501 Free article. Clinical Trial.

5

Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment.

Hong KT, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, Park KD, Shin HY, Ahn HS. Hong KT, et al. Among authors: kim h, kim ms, kim nh. J Hematol Oncol. 2012 Mar 30;5:14. doi: 10.1186/1756-8722-5-14. J Hematol Oncol. 2012. PMID: 22458355 Free PMC article.

6

Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism.

Kim H, Kang HJ, Kim HJ, Jang MK, Kim NH, Oh Y, Han BD, Choi JY, Kim CW, Lee JW, Park KD, Shin HY, Ahn HS. Kim H, et al. Among authors: kim hj, kim cw, kim nh. PLoS One. 2012;7(9):e45558. doi: 10.1371/journal.pone.0045558. Epub 2012 Sep 24. PLoS One. 2012. PMID: 23029095 Free PMC article.

7

Successful long-term use of imatinib mesylate in pediatric patients with sclerodermatous chronic GVHD.

Kim H, Kim NH, Kang HJ, Lee JW, Kim MS, Park KD, Shin HY, Ahn HS. Kim H, et al. Among authors: kim ms, kim nh. Pediatr Transplant. 2012 Dec;16(8):910-2. doi: 10.1111/petr.12004. Epub 2012 Oct 11. Pediatr Transplant. 2012. PMID: 23050745 No abstract available.

8

Clinical characteristics of pediatric thalassemia in Korea: a single institute experience.

Hong CR, Kang HJ, Lee JW, Kim H, Kim NH, Park KD, Park JD, Seong MW, Park SS, Shin HY, Ahn HS. Hong CR, et al. Among authors: kim h, kim nh. J Korean Med Sci. 2013 Nov;28(11):1645-9. doi: 10.3346/jkms.2013.28.11.1645. Epub 2013 Oct 31. J Korean Med Sci. 2013. PMID: 24265529 Free PMC article.

9

Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients.

Lee JW, Kang HJ, Kim S, Lee SH, Yu KS, Kim NH, Jang MK, Kim H, Song SH, Park JD, Park KD, Shin HY, Jang IJ, Ahn HS. Lee JW, et al. Among authors: kim h, kim s, kim nh. Biol Blood Marrow Transplant. 2015 Jan;21(1):190-5. doi: 10.1016/j.bbmt.2014.09.013. Epub 2014 Sep 22. Biol Blood Marrow Transplant. 2015. PMID: 25255163 Free article.

10

An open-label, single-arm, phase I study to evaluate the safety and immunogenicity of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, in healthy adult volunteers.

Kim N, Choi G, Lim CY, Lee JW, Kim KH, Lee HJ. Kim N, et al. Arch Pharm Res. 2010 Jun;33(6):919-24. doi: 10.1007/s12272-010-0615-5. Epub 2010 Jul 6. Arch Pharm Res. 2010. PMID: 20607497 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,365 results

Search Page

Filters